Patients with well-controlled inflammatory arthritis (IA) who abruptly discontinue adalimumab are likely to have higher flare rates than those who …
Patients with well-controlled inflammatory arthritis (IA) who abruptly discontinue adalimumab are likely to have higher flare rates than those who …